Cargando…
P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430972/ http://dx.doi.org/10.1097/01.HS9.0000971440.18283.04 |
| _version_ | 1785091087772155904 |
|---|---|
| author | Zhang, Huilai Cheng, Ying Yang, Hai-Yan Zhang, Liling Zou, Liqun Guo, Ye Cao, Junning Huang, Huiqiang Wang, Zhao Huang, Sha Liang, Zhiyu Lyu, Jiaoyan Fang, Yiqian Cohen, Aileen Zhou, Keshu |
| author_facet | Zhang, Huilai Cheng, Ying Yang, Hai-Yan Zhang, Liling Zou, Liqun Guo, Ye Cao, Junning Huang, Huiqiang Wang, Zhao Huang, Sha Liang, Zhiyu Lyu, Jiaoyan Fang, Yiqian Cohen, Aileen Zhou, Keshu |
| author_sort | Zhang, Huilai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430972 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309722023-08-17 P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA Zhang, Huilai Cheng, Ying Yang, Hai-Yan Zhang, Liling Zou, Liqun Guo, Ye Cao, Junning Huang, Huiqiang Wang, Zhao Huang, Sha Liang, Zhiyu Lyu, Jiaoyan Fang, Yiqian Cohen, Aileen Zhou, Keshu Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430972/ http://dx.doi.org/10.1097/01.HS9.0000971440.18283.04 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhang, Huilai Cheng, Ying Yang, Hai-Yan Zhang, Liling Zou, Liqun Guo, Ye Cao, Junning Huang, Huiqiang Wang, Zhao Huang, Sha Liang, Zhiyu Lyu, Jiaoyan Fang, Yiqian Cohen, Aileen Zhou, Keshu P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title | P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_full | P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_fullStr | P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_full_unstemmed | P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_short | P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_sort | p1136: first interim analysis of a phase 1 study of zanubrutinib plus lenalidomide in patients with relapsed/refractory diffuse large b-cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430972/ http://dx.doi.org/10.1097/01.HS9.0000971440.18283.04 |
| work_keys_str_mv | AT zhanghuilai p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT chengying p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT yanghaiyan p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT zhangliling p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT zouliqun p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT guoye p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT caojunning p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT huanghuiqiang p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT wangzhao p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT huangsha p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT liangzhiyu p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT lyujiaoyan p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT fangyiqian p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT cohenaileen p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT zhoukeshu p1136firstinterimanalysisofaphase1studyofzanubrutinibpluslenalidomideinpatientswithrelapsedrefractorydiffuselargebcelllymphoma |